Abbreviations used ISAAC: International Study of Asthma and Allergies in Childhood
OFC: Oral food challenge sIgE: Specific IgE SPT: Skin prick test on self-report or measures of sensitization, both of which are known to overestimate the prevalence of food allergy. One of the first studies to use a population-based sampling frame and systematic approach to measuring food allergy using the goldstandard oral food challenge (OFC), irrespective of skin prick test (SPT) wheal size, was the HealthNuts study in Melbourne, Australia. 5 We reported on the prevalence of food allergy when 2800 participants had been recruited into the study and found that more than 10% had challenge-confirmed food allergy at age 1 year, which is higher than emerging prevalence reports in other countries, which range from 1% to 6%. [5] [6] [7] [8] [9] [10] [11] However, these estimates are largely derived from infants and the populationbased prevalence of challenge-confirmed food allergy in older children remains largely unknown.
The aims of this study were to report the updated prevalence of food allergy at age 1 year from the whole cohort, and to report the prevalence of challenge-confirmed food allergy and other allergic diseases including asthma, eczema, and allergic rhinitis, at age 4 years.
METHODS

Study design
Recruitment. The HealthNuts study is a population-based, longitudinal food allergy study undertaken in Melbourne, Australia. The recruitment methods have been described in detail previously. 12, 13 Briefly, 5276 twelvemonth-old infants were recruited (74% participation) from council-run immunization sessions where they underwent SPT screening to 4 common food allergens: egg, peanut, sesame, and either cow's milk or shrimp. Any infant with a detectable SPT wheal (> _1 mm) was invited for a food challenge at Melbourne's Royal Children's Hospital. SPT was repeated on the day of challenge and blood was taken to measure serum specific IgE (sIgE) (both of which were used to define sensitization status). If SPT result was negative (0 mm) at community recruitment, infants were considered to be food tolerant. To test this assumption, a random sample of 200 infants (SPT wheal 0 mm) underwent OFC to egg or peanut and all were tolerant.
Age 4-year follow-up. The first longitudinal follow-up on the entire cohort was undertaken in the child's fourth year, as previously described. 12 Parents were mailed a questionnaire that captured information on the child's diet, adverse reactions to foods, other allergy symptoms, environmental exposures, and quality of life. Questions on key allergic outcomes (asthma, eczema, and allergic rhinitis) included those from the validated International Study of Asthma and Allergies in Childhood (ISAAC). If parents did not return the questionnaire, a reminder system was followed and if after the final reminder phone call parents had not returned the questionnaire, they were asked to complete a short 5-minute telephone questionnaire that captured essential information on their child's current allergy status.
Two pathways triggered an invitation for clinical assessment. Any child who had previously attended the HealthNuts study clinic at age 1 year was invited for a clinical allergy assessment. In addition, if parents reported in a questionnaire that their child had reacted to a food since age 12 months, and telephone screening by a study nurse revealed that the symptoms were consistent with IgE-mediated food allergy, the child was also invited to the study clinic for an allergy assessment. If parents reported symptoms that were not consistent with IgE-mediated food allergy, or that the symptoms were no longer occurring and the child could tolerate the food, children did not undergo further assessment.
The clinical allergy assessment consisted of clinical history, SPT, blood test for sIgE, and possible OFC. If the child had a positive OFC at age 1 year, they underwent repeat OFC at age 4 years to test for the persistence or resolution of food allergy. Children who were sensitized to a food but had a negative OFC at age 1 year and those who reported symptoms of a new food allergy initially underwent SPT. If SPT demonstrated evidence of sensitization and there was no history of ingestion and tolerance, or if there was a history of ingestion and reaction, participants were offered OFC to these foods. Children did not participate in an OFC if they had a reaction to the index food within the previous 1 month for egg or 2 months for peanut and sesame that was consistent with our OFC-stopping criteria and were considered food allergic. OFC, SPT, and sIgE at age 1 and 4 years followed the same protocol. 12 SPTs and serum sIgE. SPTs were administered with a single-tine lancet (Stallergenes, Antony, France) on the child's back using allergen extracts (ALK-Abello, Madrid, Spain) along with a positive control (10 mg/ mL histamine) and a negative control (saline). Blood samples were collected at both ages and plasma was isolated for sIgE assays using the ImmunoCAP System FEIA (Phadia AB, Uppsala, Sweden).
Oral food challenges. OFCs were conducted as previously described with challenge staff blinded to SPT wheal size and clinical history. 13, 14 Criteria for a positive OFC were more than 3 noncontact urticarial reactions lasting more than 5 minutes, angioedema, vomiting, or anaphylaxis, within 2 hours of the last challenge dose. On discharge those with a negative challenge were administered a single serving of the challenge food at home for 7 days to capture any late reactions. Additional information on the clinical assessments (SPT and OFC) is included in this article's Online Repository at www.jacionline.org.
Definitions for age 1-year allergy outcomes. Challengeconfirmed food allergy: Positive OFC (or recent reaction consistent with OFCstopping criteria) and positive test of sensitization (SPT wheal > _ 2 mm and/or sIgE > _ 0.35 kU/L).
Food tolerance: Negative OFC or SPT wheal 0 mm at community recruitment.
Eczema diagnosis: Parent report of a doctor diagnosis of eczema. Wheeze: Parent report of wheeze ever in the first year of life.
Definitions for age 4-year allergy outcomes. Challengeconfirmed food allergy: Positive OFC (or recent reaction consistent with OFCstopping criteria) and positive test of sensitization (SPT wheal > _ 3 mm and/or sIgE > _ 0.35 kU/L). Food tolerance: Negative OFC; or food tolerant (or missing) at age 1 year and did not present through age 4-year screening process with a new food allergy.
Probable and possible food allergy and tolerance: Participants who were eligible for but declined a food challenge were assigned a probable or possible food allergy status on the basis of SPT responses and/or clinical history (for full definitions, see this article's Methods section and Fig E1 in the Online Repository at www.jacionline.org).
The definitions for other allergic outcomes obtained from the full questionnaire, using the ISAAC questions, are as follows (for a full list of questions and definitions, see Table E2 in this article's Online Repository at www.jacionline.org).
Parent-report asthma ever: Parent report of asthma ever. Doctor-diagnosed asthma ever: Parent report of doctor diagnosis of asthma ever.
Current asthma: Asthma diagnosis and either wheeze or asthma medication use in last 12 months.
Wheeze ever: Parent report of wheeze ever. Current wheeze: Parent report of wheeze in the last 12 months. Itchy rash ever: Parent report of an itchy rash ever. Doctor-diagnosed eczema ever: Parent report of a doctor diagnosis of eczema ever.
Current eczema: Parent report of an itchy rash in the last 12 months that affected typical eczema locations, for example, folds of elbows and knees.
Nose symptoms ever: Sneezing or runny/blocked nose when child did not have cold/flu.
Nose symptoms current: Nose symptoms in the last 12 months.
Current allergic rhinitis:
Nose symptoms in the last 12 months that was accompanied by itchy watery eyes.
Parent-report allergic rhinitis ever: Parent report that their child had had allergic rhinitis ever.
Doctor-diagnosed allergic rhinitis ever: Parent report of a doctor diagnosis of allergic rhinitis ever.
Ethical conduct in human research. Approval to conduct the HealthNuts study was obtained from the Victorian State Government Office for Children (reference no. CDF/07/492), the Victorian State Government Department of Human Services (reference no. 10/07), and the Royal Children's Hospital Human Research Ethics Committee (reference no. 27047).
Statistical methods. The population prevalence of each binary outcome variable was estimated as the observed proportion, with CIs calculated assuming a binomial sampling distribution. Data on all age 1-year outcomes and food allergy at ages 1 and 4 years are presented for the whole cohort, whereas analyses on other allergy age 4-year outcomes were primarily conducted on participants who completed the full written questionnaire. To assess for potential selection bias in presentation of the age 4-year outcomes on the reduced cohort, characteristics of the participants who completed the full questionnaire, the short questionnaire, and of nonparticipants were compared using Pearson chi-square test. To assess whether the prevalence estimates were influenced by characteristics that were associated with participation at age 4 years, we calculated sampling weights that were used to adjust via reweighting the observed prevalence to reflect the distribution of risk factors among those approached to consider participation rather than among only those who completed the full questionnaire. The weights were the inverse of the predicted probability of participation obtained after fitting a logistic regression model including as covariates risk factors that were associated with completion of the full questionnaire rather than the short questionnaire or nonparticipation (child's sex, socioeconomic status, family history of allergy, parents' country of birth, and whether or not the child had challenge-confirmed food allergy at age 1 year); that is, we calculated a propensity score for each participant. 15 A sensitivity analysis was also conducted where the prevalence of allergies was calculated separately among respondents of the full and short questionnaires. Prevalence estimates were combined where an identical question was asked in both the full and short questionnaires.
RESULTS Participation
Participation in the HealthNuts study at age 1 year has been described in detail previously; therefore, Fig 1 describes participation in the age 4-year follow-up. 5, 12, 13, 16 At age 4 years, 81.3% of parents completed a questionnaire (n 5 4291); of these, 73% completed the full questionnaire and 27% completed a short telephone questionnaire. Among children who were food allergic at age 1 year (n 5 539), 89% completed a questionnaire and of these, 65% attended the HealthNuts study clinic for assessment. Parents reported symptoms of a new reaction to a food since age 1 year in 472 children; however, following telephone screening to rule out likely non-IgE-mediated or resolved reactions, only 159 attended the study clinic for assessment and 81 underwent OFC. Overall, 592 children attended the study and 356 underwent OFC to 1 or more foods. OFCs were most commonly undertaken to the following 4 foods: egg (n 5 190), peanut (n 5 147), cashew (n 5 80), and sesame (n 5 36) (for a list of OFCs undertaken to other foods, see Table E1 in this article's Online Repository at www.jacionline.org).
Demographic characteristics of the cohort, including differences in characteristics between responders and nonresponders at age 4 years, are described in Table I . Children with food allergy at age 1 year, a family history of allergy, Australian-born parents, and a higher socioeconomic status were more likely to participate at age 4 years. There were few characteristic differences between food-allergic children who did and did not attend the study clinic at age 4 years; attendees were more likely to have Australian-born parents, eczema at age 1 year, and other allergies at age 4 years (see Table E2 ).
Food allergy
Table II presents the updated prevalence of challenge-proven food allergy using the entire cohort (n 5 5276). At age 1 year, the prevalence of peanut allergy was 3.1% (95% CI, 2.7% to 3.6%), that of egg allergy was 9.5% (95% CI, 8.7% to 10.3%), that of sesame allergy was 0.6% (95% CI, 0.5% to 0.9%), and that of cow's milk allergy was 1.5% (95% CI, 1.1% to 2.1%).
At age 4 years, using our strictest definition of challengeconfirmed food allergy, the prevalence of peanut allergy was 1.9% (95% CI, 1.6% to 2.3%), that of egg allergy was 1.2% (95% CI, 0.9% to 1.6%), and that of sesame allergy was 0.4% (95% CI, 0.3% to 0.6%) (Table III) . Using the less stringent definitions, the prevalence of probable and possible food allergies was similar to each other. As expected, the prevalence of challenge-confirmed food allergy to any food at age 4 years was lower than that at age 1 year, 3.8% (95% CI, 3.3% to 4.4%) versus 11.0% (95% CI, 10.1% to 11.9%), respectively (Fig 2) .
Late-onset food allergies
There were 12 (0.2%) cases of late-onset challenge-confirmed peanut allergy at age 4 years among children who were assessed as tolerant to peanut at age 1 year; 7 of these children were SPT negative to peanut at age 1 year. A further 6 cases of peanut allergy were confirmed at age 4 years in children who had an inconclusive peanut allergy status at age 1 year. There were 4 cases of late-onset sesame allergy and no cases of late-onset egg allergy. Cashew was the most commonly presenting new food allergy at age 4 years (n 5 48); 34 cases of cashew allergy occurred in children who were allergic to other foods at age 1 year and a further 9 and 5 cases occurred in children whose food allergy status was tolerant or missing at age 1 year, respectively. SPTwas available in 44 of these children at age 1 year and 34 were sensitized to cashew at age 1 year.
Asthma and wheeze
Estimates reported for the allergic outcomes of asthma, eczema, and allergic rhinitis are the weighted-population prevalence to better reflect the full sample. Among respondents of the full questionnaire (n 5 3142), the prevalence of a parent-reported doctor diagnosis of asthma ever was 13.8% (95% CI, 11.6% to 14.1%) and the prevalence of current asthma was 10.8% (95% CI, 9.7% to 12.1%) (Table IV) . A higher proportion reported that their child had experienced a wheezing episode ever, 27.0% (95% CI, 25.4% to 28.7%), and nearly 1 in 5 children had experienced a wheezing episode in the preceding 12 months (18.0%; 95% CI, 16.6% to 19.5%). Few parents reported severe wheeze symptoms. *When comparing only participants (full and short questionnaires combined) and nonparticipants, there was no significant difference between wheezing in the first year of life (17.6% vs 18.8 %; P 5 .43) and it was not included in calculation of sampling weights.
Eczema
At age 4 years, 27.6% (95% CI, 26.0% to 29.3%) of parents reported that their child had ever been diagnosed with eczema by a doctor. This was similar to the prevalence of doctor-diagnosed eczema at age 1 year, 26.6% (95% CI, 25.4% to 27.8%), although among those with a diagnosis of eczema at age 4 years, 33% had new-onset eczema and had not reported a diagnosis of eczema at age 12 months. The prevalence of current eczema with active symptoms in the last 12 months was 16.0% (95% CI, 14.7% to 17.4%).
Allergic rhinitis
The prevalence of parent-reported allergic rhinitis ever was 11.4% (95% CI, 10.2% to 12.7%), whereas the prevalence of doctor-diagnosed allergic rhinitis was lower (3.6%; 95% CI, 2.9% to 4.4%). A higher proportion reported that their child had sneezing and runny or blocked nose when they did not have a cold or flu (19.3%; 95% CI, 17.8% to 20.8%) and most reported that these symptoms had occurred in the previous 12 months (16.9%; 95% CI, 15.5% to 18.4%). The prevalence of current allergic rhinitis (current nose symptoms and itchy eyes) was 8.3% (95% CI, 7.2% to 9.4%).
Prevalence of allergic disease in the first 4 years of life
The prevalence of any allergic disease (challenge-confirmed food allergy or doctor-diagnosed eczema) at age 1 year was 32.1% (95% CI, 30.8% to 33.5%). This was similar to the prevalence of current allergic disease (challenge-confirmed food allergy or current asthma, eczema, or allergic rhinitis) at age 4 years, 28.2% (95% CI, 26.5% to 29.9%; n 5 927 of 3135).
Using only participants with complete data on the following variables, challenge-confirmed food allergy, doctor-diagnosed allergies ever (asthma, eczema, or allergic rhinitis), or current allergies (asthma, eczema, or allergic rhinitis) (n 5 2907), 50.5% (95% CI, 48.7% to 52.3%) of children reported at least 1 allergic disease in the first 4 years of life (Fig 3) . Most children, 31.1%, reported only 1 allergy; the corresponding figures for 2, 3, and 4 allergies were 13.8%, 4.6%, and 0.9%, respectively. Of those who reported an allergic disease, 62% had 1 condition, 27% had 2, 9% had 3, and 2% had 4 allergic diseases. When including participants from the whole cohort with a report of at least 1 allergy (challenge-confirmed food allergy, doctor-diagnosed or current allergies) and including those with missing data on 1 or more allergies in the denominator, 40.9% (95% CI, 39.6% to 42.2%) of children reported at least 1 allergic disease in the first 4 years of life (n 5 2152 of 5264). Again, most children were diagnosed with only 1 allergy, 28.0%; the corresponding figures for 2, 3, and 4 allergies were 9.7%, 2.7%, and 0.5%, respectively. The overlap of allergic disease at age 1 and 4 years is presented in Fig 4 .
Sensitivity analysis
Results of the short telephone questionnaire (n 5 1149) and combined estimates of both questionnaires are presented in Table  E3 in this article's Online Repository at www.jacionline.org. The prevalence of allergies was higher among those who completed the full questionnaire compared with the short questionnaire, with the exception of a doctor diagnosis of allergic rhinitis. When combining the estimates, the prevalence of allergic diseases changed only slightly from those reported from full questionnaire responses only.
DISCUSSION
In this longitudinal population-based cohort, the prevalence of food allergy fell by two-thirds from 11% at age 1 year to 3.8% at age 4 years, with resolution of egg allergy being the main driver of this change, dropping from 9.5% to 1.2%. The prevalence of peanut allergy also fell between 1 and 4 years, dropping from 3.1% to 1.9%. Despite this drop, peanut allergy was the most prevalent food allergy in 4-year-old children. The prevalence of parent-reported doctor-diagnosed eczema was stable, with 27.6% reporting a diagnosis of eczema ever in the first 4 years of life, whereas 16.0% reported current eczema, experiencing eczema symptoms in the past 12 months. The prevalence of current asthma and allergic rhinitis was 10.8% and 8.3%, respectively. Significantly, overall nearly half the cohort experienced symptoms of an allergic disease in the first 4 years of their life (40% to 50%).
The strengths of this study are the large sample size, population-based sampling frame, and high participation rate at both recruitment and follow-up (74% and 81%, respectively). Population sampling ensures that we have captured the full spectrum of food allergy at the community level rather than relying on samples from tertiary referral centers, which may be overrepresented by children with more severe allergic disease. Unlike many previous food allergy studies, this study used the gold standard OFC to objectively measure food allergy, irrespective of SPT wheal size, ensuring robust classification of true food allergy. In addition, OFCs were conducted at specific ages as opposed to previous retrospective studies on the natural history of food allergy, which often contain children of mixed age groups and irregular follow-up periods.
Several limitations of this study are acknowledged. Although the participation rate was high, there were some differences in SPT to shrimp and cow's milk was undertaken only on half the cohort. Any food allergy includes egg peanut and sesame only; it does not include cow's milk allergy because it was not food challenge confirmed. àOFCs were not conducted to cow's milk. Cow's milk allergy was defined as cow's milk sensitized on SPT or sIgE plus a parent report of a reaction consistent with IgEmediated food allergy.
J ALLERGY CLIN IMMUNOL VOLUME 140, NUMBER 1 characteristics between participants and nonparticipants at age 4 years, which resulted in the present cohort being overrepresented by participants with a family or personal history of allergic disease. To overcome this attrition bias, we have reported key estimates for asthma, eczema, and allergic rhinitis at age 4 years, which were obtained from participants of the full questionnaire only, as both observed proportions and population prevalences weighted for factors that were associated with participation (sex, socioeconomic status, family and personal history of allergy, and parents' country of birth). The prevalence of allergic outcomes at age 1 year and food allergy at age 4 years was reported for the entire HealthNuts cohort. At recruitment, a nonresponder questionnaire was used to assess potential selection bias for participation in the HealthNuts study. The most common reason for parents declining to participate in the study was because the SPT involved too many needles (28%), followed by that the child was already eating and tolerating the foods tested (25%). Only 2.9% of responders reported that the child had already been diagnosed with food allergy. Therefore, it is more likely that parents chose not to participate in the study because of known tolerance rather than known allergy. In previous publications we have weighted our key findings at age 1 year to be reflective of the general population using the nonresponder questionnaire, including previous food reactions, and found that our estimates only altered marginally (prevalence of peanut and egg allergy changed from 2.9% to 3.0% and 9.0% to 8.9% upon back-weighting 5 ). In addition, we have previously shown that the HealthNuts cohort has good external validity and is representative of the general population in Melbourne, Australia. 13 These 2 factors suggest that selection bias in this study is minimal; hence, we did not back-weight the prevalence of age 1-year outcomes or food allergy at age Denominators for the age 4-years food allergy definitions differ because some participants who had a missing or inconclusive challenge-confirmed food allergy status were assigned a probable or possible food allergy (see definitions). àA subset of infants with positive OFC to raw egg at age 1 year participated in a substudy that included a repeat OFC to raw egg at age 2 years. Because approximately 50% of these children had developed tolerance to raw egg by age 2 years, they did not participate in repeat OFC at age 4 years although information about their ongoing dietary tolerance to egg was assessed. These participants and methods have been described in detail previously. 11 §Participants were included in the numerator if they were allergic to 1 or more foods, including additional foods tested (see Table E2 ); participants were excluded from the denominator if they were tolerant to one food but missing a food allergy status to another because we could not definitively conclude that they were food tolerant. 4 years. Because of absence of data on parents' country of birth for nonresponders, the age 4-year estimates were not further back-weighted to reflect nonresponders.
Because some participants declined to undergo a food challenge at age 4 years, a definitive diagnosis of persistent or resolved food allergy could not be ascertained for all individuals food allergic at age 1 year. To overcome this, we used SPT, clinical, and/or questionnaire data to assign a probable or possible food allergy or tolerance status to these participants and a food allergy status was assigned to 84% to 89% of participants at age 4 years who were food allergic at age 1 year (depending on the food; see Fig E1 in this article's Online Repository at www. jacionline.org). The prevalence of food allergy has been presented using all 3 definitions; estimates are similar and the CIs overlap. We have chosen to highlight the challenge-confirmed food allergy outcome throughout the as article because it is the most robust estimate of food allergy relying on challenge-proven food allergy outcomes and it does not differ significantly from the less robust definitions. In addition, children who were food tolerant at age 1 year but did not participate in age 4-year follow-up were assumed to remain tolerant at age 4 years because the prevalence of late-onset food allergy was very low. To test this assumption, a sensitivity analysis was conducted and the prevalence of food allergy at age 4 years was calculated excluding these participants. When these prevalences were back-weighted to the whole cohort, prevalence estimates were nearly identical (see Table E4 in this article's Online Repository at www.jacionline.org). Our estimates of the prevalence of allergic disease in the first 4 years of life may both underestimate or overestimate the true value. Using participants with only complete data on all allergic outcomes included only those participants who completed age 4-year follow-up *Prevalence estimates for the broader Melbourne population, which were calculated by weighting the proportion of the participants who completed the full questionnaire at age 4 years using sampling weights equal to the inverse probability of the family participating in the study at age 1 year. Medication use for wheeze or asthma includes reliever, preventers, and oral steroids. and may be biased toward more allergic disease. Likewise by including participants with missing data on age 4-year outcomes as nonallergic, we may underestimate the true value because children may be incorrectly classified as never allergic because we have not captured those who went on to develop allergies but were lost to follow-up. Therefore, we believe that the true value lies somewhere between our 2 estimates. Although the gold standard was used to measure food allergy, we relied on questionnaire data to describe the other allergic conditions. Estimating the prevalence of other allergies in childhood is difficult due to both the absence of gold standard tools that are accessible in large-scale population-based studies and due to the heterogeneity of disease expression itself. Validated questionnaires are therefore commonly used. Our questionnaires included validated questions from the ISAAC to capture information of allergic diseases, as well as parental report of a doctor diagnosis. The ISAAC questionnaire was validated among 6-to 7-year-old children and unfortunately the validity of these questions in a younger age group is not known; therefore, our estimates should be interpreted within this context. Objectively measuring asthma at the population level is challenging due to the absence of a gold standard test and heterogeneity in the presentation of asthma, which is now regarded as a broad syndrome with multiple phenotypes. 17, 18 We used parent report of doctor diagnosis of asthma in conjunction with current symptoms and/or medication used to describe the prevalence of asthma; however, we acknowledge that reporting asthma in this age group may be problematic because it can be difficult to untangle true asthma from early transient wheeze of viral origin. Previous reports have found that selfreported doctor diagnosis of asthma has high specificity and medium-high sensitivity when compared with clinical methods although there is also evidence to suggest that milder symptoms may be classified as asthma. 17, 19 We previously published the prevalence of food allergy from this cohort when only the first half of the cohort had been recruited. Our prevalence estimates for the whole cohort are slightly higher than our initial prevalence publication, although still within the CIs, 5 despite documented evidence for earlier introduction of solids (including peanut and egg) in the cohort across this time period. 20 At the time of this study's inception, there were no food allergy prevalence studies using populationbased sampling and challenge-proven outcomes. Our reports of food allergy prevalence, particularly egg, were unexpectedly high, which may be reflective of the young age of our baseline sample. It should also be noted that we used the most allergenic form of egg (raw egg) to estimate prevalence at age 1 year. However, we also used this form of challenge at age 4 years and still found a significant drop in prevalence. The prevalence of peanut allergy fell from 3.1% to 1.9% between ages 1 and 4 years and that of egg allergy fell from 9.5% to 1.2%. This is consistent with previous research that approximately 20% of children will outgrow peanut allergy and 80% will develop tolerance to egg. 21, 22 As this cohort has aged and overall nearly two-thirds of food allergy has resolved, our prevalence estimates are now closer, although still higher, than international reports. In recent years, new studies have emerged using population-based sampling frames and challenge-proven food allergy outcomes. In a birth cohort of 12,000 infants from 9 countries in Europe, the Europrevall consortium reported a prevalence of challenge-proven food allergy in the first 2 years of life of 0.59% (95% CI, 0.43% to 0.80%) and 1.23% (95% CI, 0.98% to 1.51%) for milk and egg, respectively. In South Africa, the prevalence of food allergy to any food in children aged 12 to 36 months was 2.5% (95% CI, 1.2% to 3.9%), that to egg was 1.8%, and that to peanut was 1.2%. 8 In China, the prevalence of any food allergy among infants aged up to 12 months was 3.8% (95% CI, 2.5% to 5.9%), with a prevalence of 2.5% to egg and 1.3% to cow's milk. 9 Recently in Ireland, the Babies After Scope: Evaluating the Longitudinal Impact Using Neurological and Nutritional Endpoints (BASE-LINE) birth cohort reported that the prevalence of challengeconfirmed food allergy in infants up to age 2 years was 4.5% for any food, 2.9% for egg, and 1.8% for peanut. 10 The prevalence of other allergic diseases in this cohort is higher than that reported internationally, although it is well recognized that developed countries carry a greater burden of allergic disease. In 2001-2003, the ISAAC reported a global prevalence for current asthma, allergic rhinitis, and eczema of 11.7%, 8.5%, and 7.9%, respectively, in 6-to 7-year-old children. 23 For Australia specifically, the ISAAC reported the prevalence of current wheeze in 6-to 7-year-old children to be more than 20%, which is similar to our finding of 18.0%. 24 The prevalence of current eczema in 6-to 7-year-old children was higher in Australia than the global estimate; 17.1% had current eczema (years 2001-2003) , which is similar to the results reported in the present study, suggesting that the prevalence of eczema has stabilized in the last decade. 25 The prevalence of current allergic rhinitis in 6-to 7-year-old children in ISAAC was 13.5%, which is higher than our reported prevalence of 8.3%; this difference may be reflective of the difference in ages of the cohorts. 26 A longitudinal study of 4000 children in Sweden, which used similar definitions for allergic disease (parent report of doctor diagnosis) with the exception of food allergy (challengeconfirmed in the present study), 27 reported a decreasing prevalence of any allergy at age 1 and 4 years from 26% to 15%, respectively. However, in the present study, we found the prevalence of any allergy at age 1 year and current allergy at age 4 years to be similar, 32.1% and 28.2%, respectively.
In conclusion, although the prevalence of challenge-confirmed food allergy has reduced between ages 1 and 4 years, Melbourne, Australia, continues to report high rates of food allergy, eczema, and asthma compared with international estimates, with approximately 40% to 50% of the cohort reporting an allergic disease in the first 4 years of life.
Key messages: Although the prevalence of challenge-confirmed food allergy has reduced from 11% to 3.8% between ages 1 and 4 years in this population-based cohort, the prevalence of any allergic disease among 4-year-old children in Melbourne, Australia, is remarkably high. 
METHODS
Skin prick test
At recruitment, SPT was conducted to egg, peanut, sesame, and cow's milk or shrimp. At clinical assessment, SPTwas conducted to a wider panel of foods and aeroallergens than at community recruitment; food allergens tested were peanut, egg white, sesame, soy, almond, cashew, hazelnut, shrimp, cow's milk, and wheat at both ages 1 and 4 years. Aeroallergens tested were house dust mite at ages 1 and 4 years, and additionally alterneria, cladasporum, cat hair, dog hair, bermuda grass, rye grass, and birch tree at age 4 years only. Wheal size was measured after 15 minutes and calculated as the average of the longest diameter and the diameter perpendicular to it and then subtracting the negative control SPT diameter.
Oral food challenge
Participants were telephoned by a study nurse on day 2 and returned a symptom diary of any reactions that occurred following administration of the challenge food at home for 7 days. The food challenge result was deemed negative if the child tolerated the top dose of the challenge food and did not report a late reaction. Food challenges were deemed inconclusive and the parents were offered a repeat challenge if the child refused to ingest the challenge food at the clinic or if the parent reported a late reaction that did not meet the positive challenge criteria yet led the parent to remove the food from the child's diet. In addition, positive OFC results in children without any evidence of IgE sensitization to the allergen were considered inconclusive, because we could not be certain that the reaction was due to an IgE-mediated mechanism. Because some parents declined to participate in OFC at age 4 years, their children were assigned a probable or possible food allergy or tolerance status on the basis of their SPT response, clinical history, and/or questionnaire responses (see definitions).
Definitions for other allergies at age 4 years
Definition Questions The outcomes of these positive challenges were included in the ''any challengeconfirmed food allergy'' variable at age 4 years.
J ALLERGY CLIN IMMUNOL VOLUME 140, NUMBER 1 *Two versions of the short questionnaire were conducted and if the wording of the question differed between the questionnaires it is noted in the definitions below. This variable was defined as follows: Full questionnaire: yes to ''had your child ever had asthma'' and ''were you told by a doctor that your child has asthma?'' or yes to ''has your child ever had wheeze or whistling in the chest''; Short questionnaire version 1: ''Has your child ever had wheeze or whistling in the chest or a diagnosis of asthma''; Short questionnaire version 2: yes to either ''Has your child ever had asthma, wheeze or whistling in the chest'' or ''has you child been diagnosed with asthma?'' àThis variable was defined as follows: short questionnaire version 1: yes to ''Has your child been diagnosed with eczema or had an itchy rash for more than 6 months?'', short questionnaire version 2 and full questionnaire: yes to either ''Has your child ever had an itchy rash which was coming and going for at least 6 months?'' or ''Has your child ever been diagnosed with eczema?'' §This variable was defined as follows: Short questionnaire versions 1 and 2: yes to ''Has your child ever had hay fever or sneezing/runny nose when they do not have a cold of flu?'' Full questionnaire: yes to either ''Has your child ever had sneezing or runny or blocked nose when he/she DID NOT have a cold or flu?'' or ''Has your child ever had hay fever?'' *Participants who were food tolerant at age 1 year but did not participate in age 4-years follow-up were assumed to remain tolerant because the rate of new-onset food allergy was very low. A sensitivity analysis for the prevalence of food allergy at age 4 years was conducted excluding food-tolerant infants who did not participate in age 4-year follow-up; therefore, they may not have been identified as having a late-onset food allergy. These prevalences were back-weighed to the age 1-year cohort. The table presents the crude number and weighted prevalence with 95% CI. When the prevalences are weighted back to the whole cohort, they are virtually identical to those presented in the article.
